SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001558370-24-005363
Filing Date
2024-04-19
Accepted
2024-04-19 16:05:40
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B4 sngx-20231231x424b4.htm 424B4 2218035
2 GRAPHIC sngx-20231231x424b4001.jpg GRAPHIC 6865
3 GRAPHIC sngx-20231231x424b4008.jpg GRAPHIC 784
4 GRAPHIC sngx-20231231x424b4009.jpg GRAPHIC 796
5 GRAPHIC sngx-20231231x424b4024.jpg GRAPHIC 3974
  Complete submission text file 0001558370-24-005363.txt   2237112
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-276511 | Film No.: 24857758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)